The safety and effectiveness of duloxetine compared with placebo and its long-term safety and efficacy in the treatment of predominant stress urinary incontinence

Trial Profile

The safety and effectiveness of duloxetine compared with placebo and its long-term safety and efficacy in the treatment of predominant stress urinary incontinence

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2010

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Stress incontinence; Urinary incontinence
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Feb 2010 Results published in Current Medical Research and Opinion.
    • 20 Sep 2006 Status change
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top